Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AXGN
HoldPremium GrowerAxogen, Inc. · Healthcare · United States · $2.8B · Avg Vol: $44M/d
COMPANY DESCRIPTION
Axogen, Inc. is a leading medical technology company dedicated to the science of peripheral nerve repair and regeneration. The company's competitive moat is established by its comprehensive, clinically validated portfolio of nerve grafts and connectors, which are widely adopted by microsurgeons. It operates as the dominant market leader in the niche peripheral nerve reconstruction space, supported by extensive intellectual property and clinical data.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138.6M | 159.0M | 187.3M | 225.2M | 17.6% | 251.2M | 279.6M | 331.1M | 21.2% |
| EPS | -0.69 | -0.51 | -0.23 | -0.34 | — | -0.67 | — | — | — |
| Shares | 42.4M | 43.1M | 44.1M | 47.2M | +11.2% | 53.8M | — | — | — |
| Debt | 67.4M | 69.3M | 68.7M | 67.6M | 0.1% | 20.1M | — | — | — |
| Equity | 101.0M | 95.7M | 103.9M | 128.8M | 8.5% | — | — | — | — |
| Op CF | -16.1M | -5.7M | 4.5M | 0.8M | -82.1% | 15.0M | — | — | — |
| Inv CF | -3.2M | 19.3M | -10.3M | -5.3M | — | — | — | — | — |
| Fin CF | 1.8M | 2.0M | 2.3M | 10.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AXGN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AXGN | Axogen, Inc.(you) | $2.8B | 57 | Hold |
| NEOG | Neogen Corporation | $2.5B | 46 | Hold |
| ITGR | Integer Holdings Corporation | $4.3B | 68 | Buy |
| BFLY | Butterfly Network, Inc. | $2.2B | 41 | Hold |
| ENOV | Enovis Corporation | $1.4B | 45 | Hold |
| UFPT | UFP Technologies, Inc. | $2.3B | 80 | Strong Buy |
| IRMD | IRADIMED CORPORATION | $1.1B | 65 | Buy |
| SIBN | SI-BONE, Inc. | $861M | 53 | Hold |
| IRTC | iRhythm Holdings, Inc. | $4.0B | 34 | Sell |
| TMDX | TransMedics Group, Inc. | $3.1B | 28 | Sell |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.1%